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ABSTRACT 
Site ·directed mutagenesis has been used to introduce two cysteine 
residues into two hydrophilic regions of the pea vicilin 
polypeptide previously expressed in Saccharomyces cerevisiae. The 
mutated polypeptide has been expressed. The resultant protein has 
been characterised by 80S-Polyacrylamide gel electrophoresis 
(PAGE) and the presence of both inter- and intra-polypeptide 
sulphydryl bonds is indicated by bands of different mobility from 
those of the native protein. The association of mutated vicilin 
polypeptides into disulphide-bonded aggregates under non-
denaturing conditions is not a random process, trimers being the 
major species produced. 
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1 • 1 SEED STOAAOE PROTEINS • 
CHAPTER ONE 
J:NTRODUCTJ:ON 
\'2. 
The major components of tota 1 seed protein are seed storage 
proteins. These proteins accumulate in a tissue-specific manner 
in endosperm or cotyledon tissue during seed development and are 
localised in storage organelles called protein bodies. This 
packaging protects the proteins from degradation during seed 
development (Weber and Neumann, 1980). 
Generally, these proteins supply the plant with the source of 
reduced nitrogen needed during germination and early seedling 
growth and can constitute up to 70~ of total seed protein (Croy 
and Gatehouse, 1985). 
In accordance with their function of providing the germinating 
seed with a source of reduced nitrogen, the 1 egume storage 
proteins in particular are often very rich in the amino acids 
containing more nitrogen atoms: asparagine, glutamine, arginine 
and proline. Consequently, they have a low abundance of amino 
acids such as cysteine, methionine and tryptophan (Higgins, 
1984). 
Most of the protein component of human food is derived directly 
or indirectly from seed storage proteins. In developing countries 
seeds (beans, rice and grains) provide the major protein 
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component of the diet and in industrialised countries animal 
diets are enriched with cereal or legume seeds and seed protein 
concentrates. ·The nutritional value of legume seeds can be 
improved by supplementing animal feeds with the amino acids that 
are in low abundance - such as tryptophan. Alternatively, 
recombinant DNA technology could be used to improve the amino 
acid composition of the storage proteins themselves by changing 
the sequences of the storage protein genes, ON" tS-c:w- :.."'\,)e ~~~o.'I.M.."' ~ 
e&sec.~ -..,.~"' se.e~ \l\o.'O,\;~~ oc- -&e..e.~ ~-r~e:,V\ ~~..,.o.~c:..\),\'"\-~ ~u-c"\"'~ 
~~>M·,'o/IO.~ ... OVI. 
Generally, the major seed storage proteins of legumes are of the 
globulin class - that is they are soluble in dilute salt 
solutions at neutral pH, eg. phosphate-buffered saline (0.15M 
NaCl) at pH 7.5 (Croy and Gatehouse, 1985). 
These storage gl obu 1 ins are usua 11 y present in the seed as 
oligomers. After denaturation and separation by 505-PAGE, the 
globulin components are shown to be a heterogeneous mixture of 
constituent polypeptides in terms of amino acid composition, size 
and charge. An example is pea vicilin which has been shown to 
have up to 30 separable polypeptides under two-dimensional 
IEF/505-PAGE (Matta et a7, 1981). 
1 • 2 PEA VICILIN. 
Pea (Pisum sativum L.) seed storage proteins consist of two main 
immunologically distinct classes: the 11S legumin and the 75 
vicilin globulins. Together these contribute up to 70~ of total 
seed protein in pea (Croy and Gatehouse, 1985). The 75 vicilin 
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fraction is not homogeneous but contains (in addition to vicilin) 
a third storage protein, convicilin. Convicilin is 
immunologically related to vicilin and can be purified from the 
7S fraction using non-dissociating techniques (Croy et a7, 1980). 
Mature vicilin obtained from pea seeds has an Mr of 145,000 -
170,000 resulting from the trimerisation of three 50,000 Mr 
vicilin polypeptide subunits (Gatehouse et a7, 1981). Following 
trimerisation, some of the 50,000 Mr vicilin subunits are 
susceptible to post-translational cleavage or "nicking" by plant 
proteases but the overall structural integrity of the trimer is 
maintained ( Gatehouse et a 7, 1981) . Studies on vic i1 in cON As have 
confirmed the presence of two potential cleavage sites in some 
vicilin 50,000 Mr precursors. Two sites, a:a and a:~, have been 
identified (Gatehouse et a7, 1982; Gatehouse et a7, 1983 and 
Spencer et a7, 1984). A hydrophilicity profile produced from 
amino acid sequence derived from vicilin eDNA implies that the 
a:a and B:T sites lie on polar, surface regions of the molecule. 
(Croy and Gatehouse, 1985). This why the structure of the trimer 
can be mainUQned after proteolysis. 
1 • 3 SEED PROTEINS AS Fooo ADDITIVES. 
In addition to their nutritional role, seed proteins are playing 
an increasingly important role as food additives. They are used 
to control physical properties of food products during food 
processing, for stabi ising the function a 1 properties of food 
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products and as substitutes for more expensive animal proteins 
such as casein. 
The physical properties of seed storage proteins are responsible 
for the physical properties of many food products. The properties 
required are those res pons i b 1 e for emu 1 s if i cation, foam 
formation, foam stability and food texture. 
Many functional properties of these proteins rely on the native 
configuration of the protein whilst others require protein 
denaturation followed by rearrangement of the polypeptide chains 
and formation of new intra- and inter-molecular bonds. All of 
these properties are ultimately dependent on the primary 
structure of the protein encoded by the genes. 
Using genetic engineering, it should be possible to manipulate 
the structural properties of seed proteins to suit particular 
processing applications. This research investigates the role of 
mutagenesis to improve the structural properties of food proteins 
rather than nutritional quality. 
1 • 4 THE ROLE OF GENETIC ENGINEERING. 
As mentioned already, vicilin is one of the major storage 
proteins found in pea seeds. Its structure and properties are now 
well documented (Gatehouse et a7, 1984 and Wright, 1988). The 
three 50,000 Mr subunits of each vicilin molecule, though highly 
homogeneous, are in.fact, variable. At least 11 genes code for 
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the different pea vicilin subunits (Gatehouse et a1, 1983 and 
Domoney and Casey, 1985). 
The post-translational glycosylation and proteolysis of vicilin 
subunits in vivo add to the intrinsic heterogeneity of the 
protein. This heterogeneity has severely impaired in vitro 
studies attempting to relate structure to functionality. It is, 
however, a major objective of the food industry to exploit the 
functional properties of legume storage proteins such as 
gelation, emulsification and foaming. 
The use of genetic engineering and the abi 1 ity to express 
specific foreign genes in microorganisms have been suggested as 
means of producing sufficient homogeneous material to carry out 
the required function a 1 i ty studies (Watson et a 7, 1988). By using 
this approach it should be possible to modify specifically 
vicilin primary structure by mutagenesis in vitro. Such 
alterations could be made in a predictable manner on the basis 
of vicilin structural data and thus allow the effect of specific 
changes in the primary structure on the physmchemical and 
functional properties to be assesed. 
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1 • 5 USE OF YEAST AS A HOST ORGANISM. 
Yeast has a number of advantages over other organisms for 
expression of seed storage proteins. It is a eukaryote and is 
able to carry out post-translational processing reactions 
normally asociated with plant systems. It is already widely used 
in the food industry - notably for brewing and breadmaking; it 
is non-toxic and is "Genera 11 y Regarded As Safe... As a host 
organism, yeast has a rapid growth cycle and can be continuous 
or batch cultured in a fermenter. Also, it is relatively easy to 
purify the proteins produced. 
1 • 6 THE YEAST EXPRESSION SYSTEM. 
pMA257 (shown below) is an expression vector derived from the 2~m 
high copy number, autonomously replicating S.cerevisiae plasmid 
(Tuite et a7, 1982). Transcription and translation from this 
c& 
yields a number of proteins. By the incorporation>-.storage seed ~o.~e. 
protein cDNAs into these plasmids, it is possible· to produce 
strains of yeast in which up to 5% of the total yeast protein is 
that of the encoded seed storage protein. 
RESTRICTION MAP OF PMA257: 
3300 1*1diU 
...... 
is! 
8400bp 
pMA257 
1 . 7 EXPReSSION OF PEA VICILIN BY YEAST. 
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.. 8400 
The construct pDUB2018 contains the complete coding sequence for 
a 50,000 Mr vicilin polypeptide cloned into the expression site 
of pMA257 1 • This construct has been described previously (Watson 
et a1, 1988) and when transformed into S.cerevisiae (MC16) 
expresses the vicilin eDNA. The encoded polypeptide is localized 
in the yeast cytosol and migrates as a single species in SDS-
1A restriction map of pDUB2018 is shown in figure 6, chapter 
three. 
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PAGE with an Mr of approximately 53,000. This is significantly 
higher than the 50,000 Mr subunit of native pea vicilin but is 
most probably due to the additional 22 amino acid residues of PGK 
(approximately 3,000 Mr) at the N-terminal end encoded by the 
fusion construct. 
A 1 litre culture of pDUB2018 (MC16) grown in selective (minimal) 
medium yields around 200mg of soluble protein around 5% of which 
is vic i 1 in. This homogeneous, non-g 1 ycosy 1 a ted, non-
proteolytically processed vicilin does not aggregate into trimers 
but has provided the basis for a certain amount of physirochemical 
characterisation and was the starting point for this piece of 
research. 
Amino acid analysis has confirmed that vicilin contains no 
sulphur-containing amino acids such as cysteine or methionine 
(Gatehouse et a7, 1984). This investigation sets out firstly to 
demonstrate that introduction of a methionine residue into 
vicilin will produce a polypeptide cleavable by cyanogen bromide. 
After testing the in vitro mutagenesis system in this way the 
system was used to introduce changes into the vicilin molecule 
planned on the basis of structural information about the native 
vicilin molecule. 
Cysteine residues were to be introduced at the N-terminal of 
vicilin and 3 amino acids N-terminal of the potential a:B 
cleavage site. The complete sequence of the vicilin eDNA (showing 
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the sites of oligonucleotide hybidisation) is shown in appendix 
I. 
The regions into which cysteine residues were incorporated are 
both in hydrophilic areas of the vicilin polypeptide and are thus 
likely to be on the surface of the molecule. In addition, the 
proximity of the second cysteine residue to the potential 
proteolysis site suggests that this residue is exposed. 
It was predicted that the exposed sulphydryl groups introduced 
into the vicil in 50,000 Mr subunit might make possible S-S 
bonding within the vicilin molecule and give rise to polypeptides 
of increased mobility (as detected by SDS-PAGE). Alternatively 
S-S bonding between adjacent vicilin molecules might aid 
aggregation of vicilin polypeptides and make possible 
trimerisation into molecules more like mature pea vicilin. 
2 • 1 CHEMICALS. 
CHAPTER TWO 
MATERIALS AND METHODS 
Ampicillin, adenosine triphosphate (ATP), bovine serum albumin 
(BSA), dithiothreitol (OTT), ethidium bromide (EtBr), herring 
sperm DNA, isopropylthio-8-D-galactoside (IPTG), 5-bromo-4-
chloro-3-indolt;yl-B-D-galactoside (Xgal), lysozyme, polyvinyl 
pyrrol~done (PVP), rubidium chloride, MOPS, RNAase A, tricine, 
leupeptin¢, adenine, histidine, lysine, thiamine HCl, phenyl 
methyl sulphonyl fluoride (PMSF) and 3,3~diaminobenzidine (DAB) 
were from Sigma Chemical Company, Poole, Dorset, U.K. 
Peroxidase-linked goat anti-(rabbit IgG) secondary antibody was 
from Bio-Rad Laboratories, Watford, Hertfor~ire, U.K. 
Affinity- purified rabbit anti-(pea vici 1 in) antibodies were 
purified as described previously (Croy et a7, 1980). 
HA-Ultrogel (hydroxyapatite) was from Life Science Laboratories, 
Luton, Bedfordhire, U.K. 
10/10 high resolution fast protein liquid chromatography 
(f. p. 1. c. ) co 1 umn and sephadex G-50 were from Pharmac i a LKB, 
Uppsala, Sweden. 
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Nitrocellulose filters (BA 85, 0.45~m) were from Schleicher and 
Schuell, Anderman and Co. Ltd., Kingston-upon-Thames, Surrey, 
U.K. 
Bacto-agar, Bacto-tryptone, yeast nitrogen base and yeast extract 
were from Difco Laboratories, Detroit, Michigan, U.S.A, 
Whatman 3MM paper was from Whatman Ltd., Maidstone, Kent, U.K. 
Restriction endonucleases and DNA-modifying enzymes were from 
NBL, Cramlington, Northumberland, U.K. and Boehringer Mannheim, 
Penzberg, FRG. 
M13 DNA sequencing kit was from Boehringer Mannheim, nick 
translation kit, in vitro mutagenesis kit, Hybond-N nylon 
membrane and radionucleotides were from Amersham International 
PLC, Amersham, Buckinghamshire, U.K. 
All other reagents were obtained from BDH Chemicals Ltd., Poole, 
Dorset, U.K., and were of analytical grade or the best available. 
Unless otherwise indicated, solutions were sterilised by 
autoclaving. 
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2 . 2 BACTERIAL AND YEAST STRAINS. 
Eschericia coli 910 (recB- rece-) was provided by W.J.Brammar. 
The Escheridia co 1 i strain used was TG1 ( K 12, ( 1 ac-
pro),SupE, thi,hsdD5/F', traD36,proA+B-, laci 9 , lacZ, M15)(Amersham, 
England). The yeast strain used was Saccharomyces cerevisiae MC16 
(ade2-1, leu2-3, lys2-1 ,his4-712F5 ,SUF2), (Beggs, 1978). 
2 • 3 PLASMIDS • 
The E. Coli plasmids pUC18 and pUC19 and the bacteriophage M13, 
mp18 and mp19 were obtained from Boehringer Mannheim. The yeast 
expression vector pMA257 was supplied by Dr. A J Kingsman and Dr. 
S M Kingsman (Tuite et a7, 1982). The expressed vicilin eDNA 
clone pDUB2018 was supplied by Dr. M D Watson (Watson et a1, 
1 988) . 
2 . 4 GRownt MEDIA. 
M9 salts (1x) 
Na2 HP04 
KH 2P04 
NH 4Cl 
NaCl 
YT Broth 
6g/litre 
3g 
1g 
O.Sg 
Bacto tryptone 8g/litre 
Yeast Extract Sg 
NaCl Sg 
Glucose/minimal medium 
M9 salts with 15g agar 
1M MgS04 1M thiamine HCl 
o. 1M cac 12 
20% glucose 
2xYT Broth 
16g/litre 
10g 
5g 
11 i tre 
1 ml 
1 ml 
1 ml 
10ml 
YT Agar and 2xYT Agar: 15g/litre bacto agar were added to YT or 
2xYT broth respectively to give sufficient medium for 40 plates. 
H-top Agar 
Bacto tryptone 10g/litre 
NaCl 8g 
Bacto agar Sg 
YMM Broth 
Yeast nitrogen base 6.7g/litre 
o~glucose 20g 
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YEM Broth 
Yeast extract 10g/litre 
Bacto peptone 20g 
D-glucose 20g 
Supplemented with 5~g/ml 
adenine (filter sterilized) 
YEM Agar and YMM Agar 
15g/litre bacto agar were 
added to YEM or YMM broth 
respectively to give suffi-
cient medium for 30 plates. 
YMM Media were supplemented with 50~g/ml each of adenine, 
histidine and lysine (filter sterilized). 
2 • 5 BUFFERS AND SOLUTIONS • 
TE buffer 
10mM Tris-HCl 
1mM EDTA 
pH adjusted to 8.0 with HCl 
10x kinase buffer 
1M Tris pH8.0 
1 OOmM MgC1 2 Filter sterilized OTT added 
to 70mM and ATP to 10mM.* 
*ATP omitted when used for labelling DNA with [Y-32P]ATP. 
25xTAE gel buffer (pHS.O) 
Tris 242g/litre 
Glacial acetic acid 57.1ml 
Na2 EDTA 37.2g 
10x Gel loading dye 
Glycerol 
25xTAE 
1% SDS 
0.5M EDTA 
Bromophenol 
2.8ml 
0.2ml 
1. Oml 
1. Oml 
blue 1mg 
EtBr solution 
5mg/ml stock in H20 
used 1/5000 in agarose gels 
and running buffers. 
Kenacid blue stain 
0.05% kenacid blue in 50% 
methanol, 7% acetic acid. 
Destain: 50% methanol, 7% 
acetic acid. 
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Transformation Buffer 1 Transformation Buffer 2 
RbCl 12g/litre MOPS 20ml of 0. 5M pH6. 8 stock 
MnC 124H20 9. 9g 
Potassium acetate 30ml of 
1M stock, pH7.5 
Glycerol 150g 
Adjusted to pH5.8 with acetic 
acid. 
per litre. 
RbCl 
CaC1 2 2H20 Glycerol 
MOPS adjusted to 
NaOH. 
1.2g 
11. Og 
150g 
pH6.8 with 
Transformation buffers 1 and 2 were steri 1 i zed by filtration 
through pre-rinsed sterile 0.22~m membrane filters. 
PEG/NaCl solution 
Polyethylene glycol 6000 20g/100ml 
NaCl 14.6g 
30xSSC 
100xDenhardt's buffer 
Ficoll 
PVP 
BSA 
(Filter 
2g/100ml 
2g 
2g 
sterilized) 
263g NaCl and 132.3g trisodium citrate were dissolved in 800ml 
of distilled water and the pH was adjusted to 7.0 with cone NaOH. 
The volume was then adjusted to 1 litre with distilled water. 
12.5% resolving acrylamide gel solution 
25.8ml of 30% acrylamide/0.135% bisacrylamide, 22.5ml of tris 
(1M pHS.O) and 13.8ml of distilled water were mixed and degassed. 
0.6ml of 10% SDS, 1.5ml of fresh ammonium persulpha~? (15mg/ml) 
and 20~1 of tetramethylenediamine (TEMED) were tr.:-11 added and the 
gel was poured immediately. 
Stacking acrylamide gel solution 
3.0ml of 30% acrylamide/0.~35% bisacrylamide and 2.5ml of tris 
(1M pH6.8i~~~~~ mixed and degassed. 0.2ml of 10% SDS, 0.5ml of 
ammonium ~~rsulphate and 20~1 of TEMED were then added prior to 
pouring. 
Western Blotting Solutions: 
Anode buffer 1 Anode buffer 2 
0.3M tris pH10.4 
20% methanol 
0. 1% SDS 
25mM tris pH10.4 
20% methanol 
0.1% SDS 
Cathode buffer 
25mM tris pH9.0 
20% methanol 
0. 1% SDS 
40mM 6,amino-n-
hexanoic acid. 
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Blocking solution 
5~ non-fat milk powder (Marvel~, Cadbury Schweppes Ltd, 
Bournville, U.K.), 20mM tris pH7.2, 10.9~ NaCl. 
DNA Plasmid Preparation Solutions: 
Solution 1 Solution 2 
lysozyme 
glucose 
EDTA 
Tris/HClpH8.0 
2mg/ml 
50mM 
10mM 
25mM 
2 . 6 GENERAL METHODS . 
NaOH 
SDS 
0.2M 
1~ 
Solution 3 
Sodium acetate 0.1M 
tris/HClpH6.0 0.05M 
The following methods have been well documented by Maniatis et 
a7, (1982) and ·were used without modification. 
Phenol extraction and ethanol precipitation of DNA. 
Use of DNA modifying enzymes. 
Agarose gel electrophoresis of DNA. 
2. 7 !SOLATION OF DNA FRAGMENTS FROM AGAROSE GELS. 
The method used was that of electroelution (Yang et a7, 1979). 
The band of DNA was excised from the gel and placed in a narrow 
piece of dialysis tubing sealed at one end with a dialysis clip. 
The tube was topped up with 1xTAE buffer and sealed at the other 
end with a second dialysis clip so as to be of minimal volume and 
so as not to contain any air bubbles. The tube was submerged in 
1xTAE buffer in a submarine electrophoresis tank perpendicular 
to the electric field and a current of SOmA was applied for 30 
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minutes. The buffer was then pi petted out of the tubing and 
extracted once with phenol, once with phenol/chloroform and once 
with chloroform. DNA was recovered from this buffer by ethanol 
precipitation and resuspended in TE buffer. 
2 • 8 PREPARATim4 OF E. COLI CELLS C~PETENT FOR TRANSFo:tw\TI~ 
~ITH PL~ro AND REPLICATIVE Fom:1 M13 DNA. 
The method for preparation of competent E. coli cells was based 
on the protocols of Hanahan (Hanahan, 1985). 
A single E. coli TG1 or 910 colony was picked from a 
glucose/minimal medium plate, and used to inoculate 30ml of YT 
broth in a sterile 50ml polypropylene centrifuge tube. This 
culture was incubated overnight at 37°C, with moderate agitation. 
Bml of this overnight culture was added to a 2 litre flask 
containing 200ml of YT broth and this was incubated at 37°C with 
moderate agitation to O.D. 550 of 0.3. The culture was then 
collected in~50ml polypropylene centrifuge tubes and chilled 
on ice for 15 minutes. The cells were pelleted by centrifugation 
at 3000xg for 5 minutes at 4°C. The supernatant was removed and 
the pe 11 et resuspended in 16ml of transformation buffer 1 , 
incubated on ice for 15 minutes and the cells were pelleted as 
before. This cell pellet was then resuspended in 6ml of 
transformation bu~r 2 and aliquoted as 300~1 samples into 1 .5ml 
microcentrifuge tubes which were flash freezed in liquid nitrogen 
and stored at -70°C until required. 
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2.9 TRANSF~Tlm4 ~ E. COLI TG1 t1ITH M13 RIEPLICATI\IIE F~ DNA. 
A 300~1 aliquot of frozen TG1 competent cells was thawed on ice. 
1ng of M13 replicative form (RF) DNA was added in a volume of 
20~1 and the sample was gently mixed by pipetting. The sample was 
incubated on ice for 40 minutes and then heat-shocked at 42°C for 
45 seconds before being returned to ice for 5minutes. 
Whilst the cells were on ice the following mixture was prepared: 
IPTG 100mM 40~1 
X-gal 2% in dimethylformamide 
Log phase E. co 7 i ce 11 s ( 0. D. 560 0. 4) 
40~1 
200~1 
This was added to 3ml of molten (37°C) H-top agar along with the 
aliquot of transformed TG1 cells and poured immediately onto a 
prewarmed (37°C) 2xYT plate. The plate was left to set at ambient 
temperature and then incubated inverted at 37°C overnight. 
2. 10 PREPARATim4 OF SINGLE-STRANDED M13 DNA. 
5ml of 2xYT broth were inoculated with 50~1 of a fresh overnight 
culture of TG1 cells. A toothpick was then used to transfer phage 
from a single M13 plaque into this broth. This culture was 
incubated at 37°C with shaking for 6 hours and poured into five 
separate 1. 5ml microcentrifuge tubes. These tubes were cen'IYifuged 
for 5 minutes at 13,000 rpm. Supernatants were transfe~ed into 
five fresh microcentrifuge tubes. One of these tubes was then 
stored at 4°C as a phage stock. 200~1 of PEG/NaCl solution was 
added to each of the other four tubes and these were placed at 
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4°C for 60 minutes. These tubes were centrifuged as before and 
"':i.'o'-~ 
the supernatants discarded. All ~traces of PEG/NaCl solution were 
removed from the pellets with a micro-pipette and the pellets 
were resuspended in 1 00~-tl of TE buffer. These samp 1 es were 
extracted once with phenol, twice with phenol/chloroform and 
twice with chloroform before being precipitated with ethanol. All 
four final DNA pellets were resuspended together in a total 
volume of 100~-tl of TE buffer. The concentration of this DNA 
solution was estimated by O.D. 260no (1 O.D. of single stranded DNA 
being equivalent to 40~-tg/ml). The solution was then ethanol 
precipitated once more and resuspended in TE buffer to give a 
final DNA concentration of 1~-tg/~Jl. 
2. 11 OLIGONUCLEOTIDE- DIRECTED ]N VITRO MUTAGENESIS. 
The Amersham system, which is based on the method of Fritz 
Eckstein and his co-workers was used for this procedure (Taylor, 
et a7, 1985a; Taylor, et a7, 1985b; Nakamaye and Eckstein, 1986 
and Sayers et a7, 1988). All solutions and the disposable filters 
were as described in the Amersham handbook (RPN.1523). Appendix 
II details the result of a successful mutagenesis reaction as 
determined by analysis of the samples 1 - 4 taken at various 
stages of the reaction as described below. 
An oligonucleotide was first annealed to the single-stranded DNA 
template. 5~-tl of a 1~-t9/~-tl solution of single-stranded DNA 
template, 2.5~-tl of a 1.6pmol/~-tl solution of phosphorylated mutant 
oligonucleotide, 3.5~-tl of buffer 1 and 6~-tl of water were placed 
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in a 1.5ml capped microcentrifuge tube in a 70°C water bath for 
3 minutes. This tube was then transferred to a 37°C water bath 
for 30 minutes and was then placed on ice. Next the mutant DNA 
strand was synthesised and ligated. To the above annealing 
reaction were added: 5~1 of MgC1 2 solution, 19~1 of nucleotide 
mix 1, 6~1 water, 6 units of ~lenow fragment and 6 units of T4 
DNA ligase. This was then mixed by pipetting and incubated at 
16°C for 16 hours. A 1~1 sample was removed and stored at -20°C 
for subsequent analysis on an agarose gel: Sample 1. 
Following this incubation single-stranded (non-mutant) DNA was 
removed using a disposable centifugal nitrocellulose filter unit 
(supplied with the kit) to which the single-stranded DNA binds 
at high salt concentrations·. 170~1 of water and 30~1 of 5M NaCl 
were added to the reaction mix. This was then centrifuged through 
the filter unit at 1500 rpm for 5 minutes at room temperature. 
The filter unit was then washed through with 100~1 of 5M NaCl and 
the first sample and the washing combined in a fresh 
microcentrifuge tube. This sample was precipitated with ethanol 
and the DNA pellet resuspended in 25~1 of buffer 2. 
The non-mutant strand was then nicked using Neil. 10~1 of the 
filtered sample was removed and placed in a microcenbifuge tube. 
65~1 of buffer 3 and 5 units of Neil were added. The digest was 
incubated at 37°C for 90 minutes and a 10~1 sample was removed 
and stored at -20°C for subsequent analysis on an agarose gel: 
Sample 2. 
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Next the non-mutant strand was digested using exonuclease III. 
To the reaction mix above were added: 121.11 500mM NaCl, 101.11 
buffer 4 and 21.11 of a 25units/1.11 stock of exonuclease III. This 
was incubated at 37°C for 30 minutes after which the enzymes were 
inactivated by placing in a 70°C water bath for 15 minutes. A 
151.11 samp 1 e was removed and stored at -20°C for subsequent 
analysis on an agarose gel: Sample 3. 
Finally the gapped DNA was repolymerised and ligated by adding 
131.11 of nucleotide mix 2, 51.11 of MgC1 2 , 3 units of DNA polymerase 
I and 2 units of T4 DNA ligase. The sample was placed in a 16°C 
water bath and incubated for 3 hours. A 151.11 sample was removed 
and stored at -20°C for subsequent analysis an an agarose gel: 
Sample 4. 
201.11 aliquots of the final reaction mix were used to transform 
3001.11 of competent TG1 cells. 
2. 12 PREPARATION OF RADIOACTIVELY lABELLED OLIGONUCLEOTIDE PROBES. 
The following solutions were added to a 1.5ml microcentrifuge 
tube (Maniatis et a7, 1982): 1.51Jl of oligonucleotide (2.5 OD280 
units/ml ), 31.11 of kinase buffer, 301.1Ci [Y- 32P]ATP (3000Ci/mmol), 
221.11 water and 2 units of polynucleotide kinase. This reaction 
was incubated at 37°C for 30 minutes, transfe~d to a 6ml tube 
and diluted with 3ml of 6xSSC and then stored frozen at -20°C. 
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2 . 1 3 DoT- BLOT HvBRIDISATIOH OF M 1 3 SINGLE- STRANDED DNA. 
The method detailed in the Amersham handbook was employed. 
50~1 of M13 phage stock (see 2.10) were applied as a dot to a dry 
sheet of nitrocellulose using Hybridot apparatus (Hybri-Dot~, 
B.R.L. ). The filter was air dried and baked at 80°C for 1 hour in 
a vacuum oven. The filter was then pret:.yti'Fi'di~eet with 10ml of 
(6xSSC, 10xDenhardt's solution, 0.2% SOS) at 67°C for 1 hour in 
a hybridisation bag. The prehybridisation solution was then 
discarded and replaced with 4ml of label led probe from 2.12 
above. This was left to hybridise at ambient temperature for 1 
hour. The filter was then washed three times in 100ml of 6xSSC 
(5 minutes) and once in 50ml of 6xSSC at 5°C below Td (melting 
temperature) for the oligonucleotide concerned. 
The Td value of a given oligonucleotide was estimated using the 
"Wallace rule" (Suggs et a7): Td = 4 x (number of G,C base pairs) 
+ 2 x (number of A,T base pairs). 
Excess 6xSSC was shaken off the filter, which was then covered 
with plastic film and autoradiographed at -70°C with preflashed 
film and an intensifying screen for 2 hours. 
If this procedure did not give the required discrimination 
between mutant and wild type phage dots then progressively higher 
wash temperatures were used and the filter was re-
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autoradiographed. Temperatures used were 2°C below Td, then Td, 
and in some cases 2°C above Td. 
2 • 1 4 PREPARATION OF PLASMID DNA AND REPLICATIVE FoRM M 1 3 DNA FROM E. COLI CELLS. 
The method used was a modification of that used by Maniatis et 
a 7 ( 1 982) • 
Cells were harvested from 10ml YT cultures (grown overnight at 
37°C with moderate shaking, supplemented with appropriate 
antibiotics if required) by centrifugation (10xg for 10 minutes 
at 4°C). The cell pellet was resuspended in 200~1 of solution 1 
and transferred to a 1 .5ml microcentrifuge tube. 200~1 of 
solution 2 was added and the sample was placed on ice for 5 
minutes. 150~1 of solution 3 were then added and the sample was 
returned to ice for a further 5 minutes. The samp 1 e was then 
centrifuged at 13000 rpm in a microcentrifuge tube for 10 minutes 
at 4°C. The supernatant was transferred to a new microcentrifuge 
tube using a micropipette and extracted once with 
phenol/chloroform and once with chloroform. DNA was recovered by 
ethanol precipitation and resuspended in 50~1 of TE buffer (a 
concentration of approximately 500ng/~l). 
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2 . 1 5 TRANSFORMATION OF E. COLI 91 0 WITH PLASMID DNA. 
This procedure has been detailed by Maniatis et a7 (1982). 
A 300~1 aliquot of frozen, competent 910 cells was thawed slowly 
on ice. SOng of plasmid DNA were then added and the cells left 
on ice for 60 minutes. The sample was heat shocked at 42°C for 2 
minutes and then returned to ice for 5 minutes. 600~1 of YT broth 
were added and the cells were incubated at 37°C for 60 minutes. 
1 00~ 1 a 1 i quots of 1 o-1 and 1 o-2 d i 1 uti ons of this samp 1 e (in YT 
broth) were spread onto selective YT plates (ampicillin at 
100~g/ml) which were incubated at 37°C overnight. 
2 . 1 6 COLONY HYBRIDISATION ( GRUHSTEIN AND HOOHESS, 1 9 7 5 ) . 
Colonies were replica plated from a master plate onto a gridded 
nit roce 11 u 1 ose membrane that had been p 1 aced onto a YT p 1 ate 
containing ampicillin at 100~g/~l. The colonies were grown at 
37°C overnight. The membrane was removed from the plate and 
placed colony side up onto a pad of Whatman 3MM paper that had 
been soaked in O.SM sodium hydroxide in order to lyse the 
colonies and denature the DNA. After 10 minutes the membrane was 
transferred to a pad of 3MM paper soaked in 1M Tris-HCl pH 7.4. 
The membrane was removed after 2 minutes and transferred to a 
fresh 1M Tris-HCl pad for a further 2 minutes. Following this the 
membrane was placed on a 1 .SM Tris-HCl pH 7.4 pad for a final 15 
minute incubation and was then air dried. Finally the membrane 
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was baked in a vacuum oven at 80°C for 2 hours ready for 
hybridisation with the appropriate 32P-labelled probe DNA. 
2 . 1 7 CAPILLARY ( SOUTHERN) BLOTTING OF DNA . 
The method used was that of Southern ( 19 7 5) and is out 1 i ned 
below. 
After electrophoresis in agarose, DNA in the gel was denatured 
by soaking in (1.5M NaCl, 0.5M NaOH) for 15 minutes. This was 
repeated twice, leaving in the final solution for 30 minutes. 
This denaturing solution was replaced with neutralizing solution 
(1 .5M NaCl, 0.5M tris-HCl pH 7.2, 0.001M Na2EDTA). This was left 
for 30 minutes and was repeated twice. 
The gel was transferred to a bridge of Whatman 3MM paper set in 
a reservoir of 20xSSC. An Amersham Hybond-N nylon membrane was 
placed on top of the gel and 3 sheets of 3MM paper were placed 
on top of this. A stack of absorbent pads was placed on top of 
this and the stack was compressed with a glass plate and a 500g 
weight. The absorbent pads were left to wick up the 20xSSC and 
transfer the denatured DNA onto the nylon membrane. The transfer 
was allowed to proceed for 16 hours. 
After blotting, the nylon membrane was carefully removed and 
washed in 2xSSC in order to remove any adhering agarose. The 
membrane was allowed to air dry. The membrane was then wrapped 
in cling film and placed DNA side down on a standard ultraviolet 
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transilluminator for 2 minutes to cross-link the DNA onto the 
membrane ready for hybridisation with the appropriate 32P-
labelled probe DNA. 
2. 18 RADIOACTIVE LABELLING OF DNA PROBES BY NICK TRANSLATION. 
Purified DNA fragments isolated from agarose gels were 
radioactively labelled in vitro using an Amersham Nick 
Translation Kit (N.5000) which is based upon the method of Kelly 
et a7 (1970). 
In order to label 1~g of DNA to a specific activity of around 1 
x 108 dpm/~g, the following reagents were combined in a 1.5ml 
microcentrifuge tube: 1 ~g DNA (usually 1~1), 20~1 
nucleotide/buffer solution, 10~1 of [a- 32 P]dCTP solution 
(100~Ci), 10~1 of enzyme solution (klenow) and sufficient water 
to bring the final volume to 100~1. The reaction was incubated 
at 15°C for 30 minutes. 
The reaction mixture was then loaded directly onto a 10cm column 
of Sephadex G-50 suspended in buffer containing 150mM NaCl, 10mM 
EDTA, 0.1% SDS and 50mM Tris-HCl pH7 .5 in order to stop the 
reaction and to separate the labelled DNA from the unincorporated 
nucleotides. 1ml fractions were collected and samples were 
monitored for radioactivity by scintillation counting. The eluted 
labelled double-stranded DNA was pooled and used as a probe in 
hybridization experiments. 
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2. 19 DETECTION OF MEMBRANE-BOUND DNA BY HYBRIDIZATION. 
Membranes were placed in polythene bags and prehybridised at 65°C 
in 25ml of prehybridization solution (7.5ml 20xSSC, 1 .25ml 
100xDenhardt's solution, 1.25ml 10% SDS and O.Smg of denatured 
herring sperm DNA). After 1 hour's incubation the solution was 
replaced with 10ml of fresh solution and 1~g of probe DNA (1 x 
108 dpm) was added. The bag was heat-sealed and the filter was 
hybridised 25°C below the Td of the duplex for 16 hours (Bonner, 
1973). This was usually at around 65°C. 
Following hybridization, the filters were washed twice with 100ml 
of 2xSSC at 65°C for 15 minutes. This was followed by a 15 minute 
wash in 2xSSC containing 0.1%SDS (65°C, 30 minutes). The membrane 
was then wrapped in cling film and autoradiographed against pre-
flashed film at -80°C. If the required specificity of 
hybridiz~ti6n had not been achieved at this point a 10 minute 
wash in 0.1xSSC at 65°C was used. The membrane was again wrapped 
in cling film and autoradiographed as before. 
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2 . 20 DNA SEQUENCING. 
Sequencing of DNA inserts in M13 clones was according to the 
chain termination principle of Sanger et al (1977). Sequencing 
of DNA inserts in pUC vectors was also performed by the chatn 
termination principle using the method developed by Chen and 
Seeburg ( 1985). In either case the procedures were performed 
using Boehringer Mannheim sequencing kits (1013092 and 1013106 
respectively) and following exactly the protocols supplied with 
the kits. 
Where pUC inserts were sequenced, the plasmid DNA had first to 
be denatured: 2~g of plasmid DNA were placed in a 1 .5ml 
microcentrifuge tube and dried down in a vacuum centrifuge. The 
DNA was dissolved in 40~1 denaturation buffer (NaOH, 0.2M, EDTA, 
0.2mM pH8.0) and allowed to stand at room temperature .. 4~1 
neutralising buffer (ammonium acetate 2M, pH4.5) were added. The 
DNA was then precipitated with ethanol immediately. 
To the denatured and dried plasmid DNA were added: 1~1 ~ 2.5 pmol 
M13/pUC sequencing primer (solution 12), 1.5~1 10x reaction 
buffer (solution 10), 2~1 ~ 16 ~Ci [ 35S] dATP-a-S and 9.5~1 
redisti 1 led water. This mixture was incubated at 37°C for 15 
minutes. 2 units of Klenow enzyme were then added and 3~1 of the 
mixture were then pipetted into each of four labelled 
microcenbifuge tubes (G,A,T,C). 
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Where M13 inserts were sequenced, 0.5~g of single stranded M13 
DNA were combined with 1~1 ~ 2.5 pmol M13/pUC sequencing primer 
(solution 12), 1.5~1 10x reaction buffer (solution 10) and 
sufficient redistilled water to bring the reaction volume to 
10~1. This mixture was incubated for 10 minutes at 55°C and 
allowed to cool slowly to room temperature afterwards. 
2~1 ~ 16 ~Ci [ 35S] dATP-a-S and 1 unit of Klenow enzyme were then 
added to this hybridisation mixture and 2.5~1 of the mixture was 
pipetted into each of four label~d microcentrifuge tubes 
(G,A,T,C). 
In each case 2~1 of the appropriate dNTP/ddNTP mixture were added 
to each tube and the tubes were incubated for 20 minutes at 37°C. 
The dNTP/ddNTP mixes used were as listed in table 1 below. 
Nucleotide G mixture A mixture T mixture C mixture 
:sOlut ions 
"' 
j!mol/l 
"' 
j!mol/1 
"' 
j!mol/l 
"' 
j!mol/1 
dGTP (3) 2 5 40 100 40 100 40 100 
dTIP(4) 40 100 .4() 100 2 5 40 100 
dCTP (2) .4() 100 40 100 40 100 4 10 
ddGTP (5) 12 120 - - - - - -
ddATP(6) - - 10 100 - - - -
ddTIP (7) - - - - 50 500 - -
ddCTP (8) - - - - - - 10 100 
10x buffer (10) 20 20 20 20 
redist. water 86 50 48 86 
final volume 200 200 200 200 
Table 1. Composition of dNTP/ddNTP mixes used for DNA sequencing. 
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The reactions were then chased by adding 1.5~1 deoxynucleotide 
mixture (solution 11) to each microfuge tube and incubating again 
at 37°C for a further 15 minutes. 
The reactions were terminated by adding 4~ 1 formami de buffer 
(so 1 uti on 1 5) . 
Immediately before loading onto a sequencing gel the samples were 
denatured by incubation at 95°C for 3 minutes followed by rapid 
coo 1 i ng on ice. 2~ 1 of each samp 1 e were then 1 oaded into an 
appropriate slot of a pre-electrophoresed and pre-heated (65°C) 
5% polyacrylamide sequencing gel 0.2mm thick. 
After electrophoresis, the gel was dried for 1 hour at 80°C under 
vacuum. An X-ray film was exposed to the dried gel overnight at 
room temperature. DNA sequence was then read from the developed 
fi 1m. 
2 . 21 TRANSFORMATION OF S. CEREVISIAE. 
50ml of YEM media were inoculated from a fresh overnight culture 
of S.cerevisiae MC16 and grown to 0.0. 590 0.5 at 30°C. The yeast 
cells were harvested in a bench top centrifuge at 3000xg for 5 
minutes and suspended in 5ml of 1 OOmM 1 i th i um acetate in TE 
buffer. This cell-suspension was incubated at 30°C for 1 hour 
with agitation. The cells were harvested again by centrifugation 
and resuspended in a another 5m1 of 1 ithium acetate buffer 
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containing 15% g 1 ycero 1. The ce 11 s were dispensed in 3001-l 1 
aliquots in ~ppendorf tubes and frozen at -70°C until required. 
To transform the ce 1 1 s, the tubes were warmed s 1 owly to room 
temperature and 101Jg of DNA (101Jl) were added. 0.7ml of 50% PEG 
4000 was then added and the transformation mix was incubated at 
30°C for 60 minutes. The ce 1 1 s were then heat shocked at 42°C 
for 5 minutes and centrifuged at 13000 rpm for 10 minutes. All 
the PEG solution was removed with a pipette and the cells were 
resuspended in 1001-11 of TE buffer and plated out onto selective 
YMM plates. The plates were then incubated inverted at 30°C for 
5 days. 
2 . 2 2 SMALL- ScALE PROTEIN EXTRACTS . 
Small quantities of protein were extracted from yeast cultures 
by the procedure described by Watson et a7 (1988). 
Transformed yeast cultures (10ml) were grown overnight at 30°C 
with moderate shaking in YMM supplemented with the required amino 
acids. The cells were pelleted by centrifugation, cooled and 
immediately resuspended in 1001-11 of lysis buffer [1ml of 0.2M 
Tris/HCl, pH6.0 containing 0.2% SDS and 10% (w/v) sucrose, 101-11 
leupeptin (2001Jg/ml) and 101-11 phenylmethanesulphonyl fluoride 
(36mg/ml in ethanol)]. An equal volume of acid-washed glass beads 
(450-500 1-1m) was added and then the cells were vortexed for five 
bursts of 15 seconds each. The debris was removed by 
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centrifugation and the supernatant was boiled for 10 minutes 
before being subjected to SDS-PAGE or storage at -20°C. 
2. 23 SOS-POLYACRYLAMIDE GEL ELECTROPHORESIS OF YEAST PROTEINS. 
O.V\o.\~~ 
Yeast protein extracts were fractione9 by 12.5% SDS-PAGE under 
reducing conditions and non-reducing conditions (ie in both the 
presence and absence of 2-mercaptoethano 1 respective 1 y). The 
procedure used was as described by Laemmli, 1970. 
2. 24 WESTERN BLOTTING. 
Proteins fractioned by SDS-PAGE were either stained with kenacid 
blue stain (0.05% w/v in 50% methanol 7% acetic acid) or were 
transferred to nitrocellulose membranes by electroblotting 
followed by immunological detection. 
After electroblotting (Burnette, 1981), nitrocellulose membranes 
were blocked overnight at 4°C in 50ml of blocking solution. The 
blocked filter was probed with rabbit anti-vicilin as primary 
antibody and peroxidase-linked goat anti-(rabbit IgG) as 
secondary antibody. Proteins were visualised by staining for 2-
3 minutes with 50ml of a fresh solution of 1x tris/salt buffer 
containing 50mg DAB, 3m1 1% cobQlt chloride and 1001-11 H20 2 • 
Filters were then photographed. 
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2 • 2 5 LARGE SCALE PREPARATION Of YEAST PROTEINS. 
10ml stationary-phase cultures of yeast cells grown in YMM were 
used to inoculate 500ml YMM cultures in 2 litre baffled conical 
flasks. These were supplemented with the appropriate amino acids 
and incubated at 30°C with shaking for 48 hours. The cells were 
harvested by centrifugation (5000xg for 10 minutes) after this 
time (corresponding to an 00200 of approximately 3.0). 
Yeast cells were resuspended in 30ml of lysis buffer [100ml of 
0.2M Tris/HCl buffer pH6.0 containing 10% w/v sucrose, 1ml of 
leupeptin (200~g/ml) and 1ml of phenylmethanesulphonyl fluoride 
(36mg/ml in ethanol)]. An equal volume of acid washed glass beads 
(450-500~m) was added and the cells were vortexed for 5 bursts 
of 15 seconds, placing the cells on ice for 1 minute between 
vortex mixes. The extract was cent i fuged at 12000xg for 30 
minutes at 4°C and the pellet, containing intact yeast and cell 
debris was discarded. The supernatant (yeast so 1 ub 1 e extract) was 
placed on ice. 
Solid (NH 4 ) 2S04 was added slowly to the above extract with 
stirring to a final concentration of 95% relative saturation (for 
30ml of supernatant at 0°C this was 22g of solid (NH 4 ) 2S04 ). After 
15 minutes the extract was centrifuged at 12000xg for 30 minutes 
and the supernatant was discarded. 
The 95% saturation (NH 4 ) 2S04 pellet was dissolved in 10ml of 150mM 
sodium phosphate buffer pH7.5 and dialysed against 10mM sodium 
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phosphate buffer pH7. 5 for 24 hours with sever a 1 changes of 
buffer. 
h . . 9':=' . 1 T 1s extract was then fract1on on a hydroxyapat1te co umn as 
described below. 
2. 26 FAST PROTEIN LIQUID CHROMATOGRAPHY (F. P. l. C. ) • 
Di a 1 ysed protein extracts were 1 oaded onto a hydroxyapatite 
ultrogel column packed into a 10/10 glass f.p.l.c. column, 
interfaced to an LKB f.p.l.c. system with a UV1 ultraviolet 
monitor and a 280nm filter as a detection unit (Wright et a1, 
unpub 1 i shed). 
The column was pre-equilibrated in 150mM sodium phosphate buffer 
and the yeast protein was loaded in 10ml aliquots with the aid 
of a 10ml Superloop. 
Unbound material was eluted with 150mM sodium phosphate buffer~ 
Bound material (vicilin) was eluted with a linear gradient of 
increasing sodium phosphate concentration (up to 750mM). The flow 
rate throughout was 1ml/minute and all buffers used were filtered 
through 22~m pore-size filters before use. The purified vicilin 
was freeze dri•d and stored at -20°C. 
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2 • 2 7 PROTEIN ASSAY • 
Protein was estimated by ultraviolet absorption using an 
extinction coefficient E280 1cm of 0.8 for a 1 mg/ml solution of 
vicilin. 
2. 28 CNBR CLEAVAGE OF PROTEINS. 
50~g of vicilin were resuspended in 150~1 70% formic acid, 
transferted to a plastic 10ml scinti\lation vial and 200~1 of a 20% 
solution of CNBr in acetonitrile were added. The vial was sealed 
and kept at room temperature in the dark for 24 hours. 6ml of 
distilled water was then added and the sample was freeze dried. 
This procedure ensured the removal of all CNBr from the sample. 
Samples were stored dry at -20°C. 
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2. 29 VICILIN GELLING. 
The turbidity of heat-induced gels of vicilin was determined 
using an adaptation of the method that Nakamura et a7 (1984) used 
for glycinin gels. 
0. 3 00280 units of vi ci 1 in were dissolved in 500!-11 of 150mM sodi urn 
phosphate buffer pH7.5. Each protein solution was heated at a 
rate of 1°C per minute to a final temperature of 75°C and the 
formation of the protein gel was noted by following the change 
in 00450 • 
CHAPTER THREE 
THE METHIONINE MUTANT OF PEA VICILIN 
3. 1 INTRODUCTION OF A METHIONINE RESIDUE INTO PEA VICILIH. 
A sing 1 e base change was made to the vic i 1 in eDNA construct 
pDUB2018 at position 819 of the eDNA insert (see appendix I). The 
base T in pDUB2018 was changed to an A by in vitro mutagenesis. 
The mutant vic i 1 in gene was then fused to the yeast 
phosroglycerate kinase (PGK) promoter in the yeast expression 
vector pMA257. This mutant construct (pPE18) was expressed in 
S.cerevisiae to yield a vicilin fusion peptide containing the 
first~ amino acid residues of PGK in addition to the vicilin 
sequence J i dent i ca 1 to the pDUB20 1 8 peptide except that the 
leucine residue 282 has been converted to a methionine residue. 
The vici 1 in eDNA was isolated from the construct pDUB2018 by 
restriction with Bam HI, gel electrophoresis and electroelution 
of the 1.4 Kb vicilin Bam HI fragment. This fragment was ligated 
into the polylinker Bam HI site of the M13 vector mp18 which was 
then transformed into E. co 7 i TG1 (see Figure 1 ) . Sing 1 a-stranded 
DNA was purified from a number of recombinant plaques and these 
were checked by dideoxysequencing to ensure that the vicilin 
sequence was correct. A recombinant containing the vicilin eDNA 
in the 5' - 3' orientation was selected and used to make the 
single-stranded template DNA required for the 
mutagenesis. 
in vitro 
pOU8 2018 
~dill 
Bam HI 
Poly linker 
Cloning 
Sll.oa 
Cut Bam HI and 
1 i isolate vicilin 
~I .il fragment. 
I I 
CutBamHJ. 
Figure 1. Cloning of the vici7in eDNA into M13 mp19. 
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An oligonucleotide (oligo 1) of part of the antisense strand of 
vicilin was made by the phosphoramidite method on an automatic 
DNA synthesiser (Applied Biosystems model 381A) by Mr John Gilroy 
(see acknowledgements). After synthesis, the oligonucleotide was 
purified by high pressure liquid chromatography (h.p.l.c.) and 
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phosphorylated using T4 polynucleotide kinase (Berkner and Folk, 
1977). The sequence of oligo 1 is shown in figure 2. 
5' 
GG CAA CAT TAA AGA TCC 
3' 
Figure 2. Sequence of Oligonucleotide 1. 
The oligonucleotide was a~aled to the single-stranded vicilin 
template and was used to prime the in vitro mutagenesis reactions 
described in chapter 2. 
After in vitro mutagenesis and transformation into E. coli TG1, 
a number of plaques were screened for the methionine mutation. 
Putative mutant phage were grown up in 2ml 2xTY broth cultures 
overnight and 100~1 samples of phage supernatant were spotted 
onto a nitrocellulose filter using dot blot apparatus. 15pmol of 
oligo 1 was end-label led with 30~Ci [Y-32P]ATP using polynucleotide 
kinase and this was used to probe the filter as described in 
chapter 2. Figure 3 shows a 24 hour autoradiograph of a filter 
with 8 plaques after washing to 47°C (Td + 2°C) in 6xSSC. 
Replicative form DNA was prepared from the phage showing 
strongest hybridisation (sample 8, figure 3). The mutant vicilin 
eDNA was isolated from this construct by restriction with Bam HI, 
gel electrophoresis and electroelution of the 1.4 Kb vicilin Bam 
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HI fragment. This was then ligated into the Bam HI site of the 
yeast expression vector pMA257 to create pPE18 which was 
transformed into E. co7i 910. 
1 2 3 
6 7 8 
Figure 3. Dot b7ot hybridisation of putative methionine mutants 
of' vici7in in M13 probed against oligo 1. Eight samples are 
shown. The sample shown top 7eft (sample 1) is of non-mutant 
vici7in phage supernatant and serves as a negative control. The 
sample shown bottom right (sample 8) was selected as being a 
probable methionine mutant of vici7in as it showed strongest 
hybridisation to oligo 1. 
The scheme for construction of the methionine-containing vicilin 
mutant pPE18 is summarized in figure 4. 
l 
In-vitro IMage! .. of 
vicillngene i'IU13 ~. 
Ofiganucleot:id direc:f;ed leucine to n>et:hionne mul:lltian ~. 
! Mut:anl: vlcHln aubc:loned Into yeast expreaslan vectar pNIA 257 
on Barn HI fJ ~ • e it: to give final construct pPE 18. 
1 
Figure 4. Construction of methionine mutant of vicilin pPE18. 
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Plasmid DNA was prepared from a number of potential pPE18 
transformants and this was restricted with either Bam HI or 
Hindiii. SOOng samples of restricted DNA were then subjected to 
agarose gel electrophoresis on an 0.7% (w/v) agarose gel, 
Southern blotted onto a nylon membrane and probed using the 
radioactively labelled oligo 1 described above. The blot was 
washed in 1 xSSC at 42°C. Figure 5 shows a photograph of the 
ethidium bromide-stained gel and an autoradiograph of the 
Southern blot after 48 hours exposure. 
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Figure 5. Gel electrophoresis and corresponding autoradiograph 
of Southern blot used to screen for pPE18 mutant. Lane 1, 
molecular weight markers (phage lambda digested with BstEII). 
Lane 2, pDUB2018 BamHI. Lane 3, pDUB2018 Hindiii. Lanes 4 - 13, 
potential pPE18 mutants (methionine mutants of vicilin): even 
numbers are BamHI digests and odd numbers are Hindiii digests. 
Only the construct shown in lanes 8 and 9 contains the vicilin 
insert in the correct orientation for expression from the PGK 
promoter; that is to say, it yields a 1.4kb Bam HI fragment (lane 
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8) and a 2.7kb Hind III fragment (lane 9) similar to pDUB2018 
(lanes 2 and 3). Lanes 8 and 9 also show a positive hybridisation 
of the 1.4kb Bam HI and 2.7kb Hind III fragments against oligo 
1 in the Southern blot. Figure 6 shows a restriction map of 
pDUB2018 and indicates the sizes of the DNA fragments resulting 
from restriction of pDUB2018 with Bam HI and Hind III and similar 
restriction of a construct containing the vicilin insert in the 
opposite orientation. 
Restriction fragments (kb) when vicilin: 
a) cloned for expression, 
&ul HI Hfnd III Pst I 
8.4 kb 
1.4 kb 
3.7 kb 
3.4 kb 
2.7 kb 
b) cloned in opposite orientation, 
5.8 kb 
4.0 kb 
Balli HI Hfnd III Pst I 
8.4 kb 
1.4 kb 
4.3 kb 
3.4 kb 
2.1 kb 
7.1 kb 
2.7 kb 
9-'7 
~1-7 
1·8 
pOUB2018 
Figure 6. Restriction map of pDUB2018. 
ttindl&l 
-lf!!lHI 
The construct shown in lanes 8 and 9 of figure 5 was, therefore, 
designated pPE18, the vicilin insert of which was checked by 
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dideoxy sequencing in M13 to confirm the methionine mutation and 
to check that the clone was otherwise identical to pOUB2018. 
3. 2 INTROOOCTicm OF PPE 18 INTO S. CEREVISIAE. 
5~g of pPE18 DNA was used to transform 300~ 1 of competent 
S.cerevisiae MC16. 50 transformant colonies (selected on YMM 
plates) were streaked onto nitrocellulose membranes along with 
a pOUB2018(MC16) colony and a pMA257(MC16) colony. The membranes 
were placed on fresh YMM plates and incubated overnight at 30°C. 
One such plate was kept as a replicate whilst the yeast colonies 
on the nitrocellulose membrane of the second plate were lysed by 
placing the membrane on filter paper soaked in [0.1% SDS, 0.2M 
NaOH, 0.5% 2-mercaptoethanol] for 30 minutes. This filter was 
then probed with [rabbit anti-vici 1 in/goat anti-rabbit peroxidase 
complex] as described in chapter 2, section 2.24. A number of 
yeast transformants were found to be expressing vicilin at an 
apparQntly similar level to the pOUB2018(MC16) positive control. 
The pMA257(MC16) colony serves as a negative control. A 
photograph of this filter is shown in figure 7. A construct 
containing the mutated vicilin in the opposite orientation for 
expression was similarly used to transform S.cerevisiae and was 
similarly screened. In this case no transformants were seen to 
be expressing vicilin. 
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Figure 7. Western probe of potential pPE18 MC16 S.cereyisiae 
transformants against anti-(pea)vicilin. Three transformants can 
be seen to be expressing vicilin at a similar level to pDU82018. 
3 , 3 EXPRESSION OF VICILIN METHIONINE MUTANT BY YEAST . 
20ml cultures of pMA257(MC16), pOUB2018(MC16) and pPE18(MC16) 
were grown overnight at 30°C and small scale protein extracts 
were prepared as described in chapter 2. Aliquots of each protein 
extract were subjected to CNBr cleavage then all protein samples 
were analysed by SDS-PAGE (in the presence of 2-mercaptoethanol) 
and western blotting against anti-(pea)vicilin. A photograph of 
this Western blot is shown in figure 8. 
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1 2 3 4 
• • 
Figure 8. Western blot analysis or pPE18(MC16) vicilin 
(methionine) extracts. Lane 1, pPE18(MC16) protein extract 
(untreated). Lane 2, pPE18(MC16) protein extract cleaved with 
CNBr. Lane 3, pDUB2018(MC16) protein extract (untreated). 
Lane 4, pDUB2018(MC16) protein extract cleaved with CNBr. Lane 
5, pMA257(MC16) protein extract (untreated). A11 lanes contain 
20J.J1 protei nJ( approximate 1 y 10J.I9 tota 1 so 1 ub 1e protein). A 77 
lanes contain 2-mercaptoethanol. The presence or a cleaved 
vicilin product in lane 2 or approximately Mr 27,000 is shown by 
arrow a. '""<t ~-...... ..__'-"<=>""' -~ ~'IIO'r4t~ ~'"'---- ''"" 'o."'4t 'l- ~ ""'"~·~~ '~ 
~"' ........ \.v. 0""'- \o......e~ -
Figure 8 shows that the methionine mutant of vicilin produced by 
yeast is cleavable by CNBr. Non-mutant vicilin is not cleaved 
and no vicilin is produced by clones not containing the vicilin 
insert (or by clones containing the insert in the opposite 
orientation for expression). 
CHAPTER FOUR 
THE CYSTEINE MUTANTS OF PEA VICILIN 
4. 1 lNTROOUCTION OF Two CYSTEINE RESIDUES INTO PEA VICILIN. 
Serine residue 2 and serine residue 183 of pDUB2018 were 
converted to cysteine residues by the in vitro mutagenesis 
procedure to produce the intermediate constructs pPE9 and pPE11 
respectively. The mutagenesis was performed using the 
oligonucleotides oligo 2 and oligo 3 which were prepared as 
described in chapter 3. The sequences of oligos 2 and 3 are shown 
in figure 9 and the subcloning procedure used to construct pPE9 
and pPE 11 is shown in figure 1 0. The vic i 1 in eDNA sequence 
showing the sites of hybridisation for oligos 2 and 3 is given 
in appendix I. 
Oligo 2 
5' 
GG ATC ACA CCT AGA AG 
3' 
Oligo 3 
5' 
C CTT AAG GCA TCT TCT G 
3' 
Figure 9. Sequence of oligonucleotides 2 and 3. 
pDUB 2018 
!:!.!!ldW 
~HI 
Cut Bam HI and 
a: :;: isolate vicilin 
"'I -
c· E' f t :1 .a ragmen . 
I I 
~dW 
!!!!!!!HI 
Polylinkar 
c~ 
Sit.es 
Cut BanHI. 
In-vitro mutagenesis of 
vicilin gene inM13 mp18. · 
Two c.{Steine containing 
m.J tants s ubc!oofXj in to 
yeast expression vector 
pMA257. 
pPE 11 
~dUJ 
~HI 
Figure 10. Construction of pP£9 and pP£11. 
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After in vitro mutagenesis of the eDNA (by the same procedure 
used for the methionine construct) plaques were screened by dot-
blot hybridisation against labelled oligonucleotides 2 and 3 as 
described in chapters 2 and 3. A dot-blot of putative cysteine 
mutants is shown in figure 11. 
2 
e 
• 
3 
7 
• 
4 
8 
5 
9 
• 
Figure 11. Dot-blot of putative cysteine mutants. Dot 1 is M13 
mp 19 and serves as a negative contro 1 - it has been probed 
against both oligo 2 and oligo 3. Dots 2-5 are potential ser 2 
mutants probed against oligo 2. Dots 6-9 are potential ser 183 
mutants probed against oligo 3. 50~1 of phage supernatant was 
1 oaded in each case. 
Replicative form DNA was prepared from the phage show i ng 
strongest hybridisation: phage 5 in the case of the oligo 2 
mutant and phage 9 in the case of the oligo 3 mutant. The mutant 
vicilin cDNAs were isolated from these constructs by restriction 
with Bam HI, gel electrophoresis and electroelution of the 1.4 
Kb vicilin Bam HI fragments. These were then ligated into the Bam 
HI site of the yeast expression vector pMA257 and transformed 
into E. coli 910 to create pPE9 and pPE11. Constructs containing 
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the mutant vicilins in the opposite orientation to that required 
for expression by the PGK promoter were also obtained and were 
designated pPE10 and pPE12 respectively. pPE9 and pPE11 
constructs were checked by restriction, agarose gel 
electrophoresis and Southern blotting against oligos 2 and 3 as 
shown in figure 12 below. 
~ 2 3 4 
1 
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Figure 12. Agarose gel electrophoresis and Southern blot of pP£9 
and pP£11. Lane 1, DNA size markers (Lambda restricted with Bst 
EII). Lane 2, pP£9 Bam HI. Lane 3, pP£9 Bam HI/Bg1 II. Lane 4, 
pDUB2018 Bam HI. Lane 5, pP£11 Bam HI. Lane 6, pP£11 Bam HI/ 
Bgl II. Lane 7, pDUB 2018 Bam HI. Lanes 2, 3 & 4 are probed 
against oligo 2. Lanes 5, 6 & 7 are probed against oligo 3. 
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Digests of pPE9, pPE11 and pDUB2018 with Bam HI have yielded the 
expected fragments of 8.4kb and 1.4kb. Digests of pPE9 and pPE11 
with Bam HI and Bg 7 I I together have y i e 1 ded the expected 
fragments of 8.4kb, 1.0kb and 0.4kb. With pPE9, the 1 .4kb Bam HI 
fragment and the 0.4kb Bam HI/Bg7 II fragment hybridised against 
oligonucleotide 2 (lanes 2 and 3 of figure 12). With pPE11, the 
1.4kb Bam HI fragment and the 1.0kb Bam HI/Bg7 II fragment 
hybridised against oligonucleotide 3 (lanes 5 and 6 of figure 
12). This reflects the position of binding of the 
oligonucleotides within the vicilin insert2 • No hybridisation of 
oligonucleotide 2 to pPE11 or of oligonucleotide 3 to pPE9 was 
detected. No hybridisation of the oligonucleotides to pDUB2018 
was detected (lanes 4 and 7 of figure 12). 
4 • 2 EXPRESSION OF CYSTEINE MUTANTS BY S. CEREVISIAE. 
pPE9, pPE10, pPE11 and pPE12 were transformed into S.cerevisiae 
MC16 as described in chapter 3. 10ml transformant yeast cultures 
were grown up overnight in YMM broth in each case. Similar 
cultures of pDUB2018(MC16) and pMA257(MC16) were also produced. 
Small scale protein extracts of all these cultures were prepared 
under the denaturing conditions described in chapter 2 and 20~1 
aliquots of these extracts were analysed by SDS-PAGE and Western 
blot. The results of this analysis are shown in figure 13. 
2See also figure 6 in chapter three. 
Mr 
71000 
50000 
!. 
.., 
71000 
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12 34567 
• 
12345 6 7 
Figure 13. SDS-PAGE and subsequent western blot analysis of 
protein extracts from cysteine-containing vicilin mutants 
produced by yeast. Lane 1, Vicilin/Convicilin Standards. Lane 2, 
pPE9(MC16). Lane 3, pPE10(MC16). Lane 4, pPE11(MC16). Lane 5, 
pPE12(MC16). Lane 6, pDUB2018(MC16). Lane 7 pMA257(MC16). 
P\o.\-e A. -;.\-,au:)~ a. \(~ Q.c.\a ~\ue s\-n\""~ ~Q.\ . 
\>\G.\-Q. ~ s~~ eo-. ~~'(V\ '¥J\o~ ().V\(1.\"j-o\s, o[r 0.. $\w~\o.., 0~l. 
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The constructs pPE9 (MC16), pPE11 (MC16) and pDUB2018 (MC16) 
produce a 53,000 Mr vicilin (lanes 2, 4 and 6 of figure 13 
respectively). Constructs pPE10 (MC16), pPE12 (MC16) and pMA257 
(MC16) do not produce a vicilin product (lanes 3, 5 and 7 of 
figure 13). 
In figure 14, a similar western blot of pPE9 and pPE11 protein 
extracts is shown but in this case only lanes 1 to 5 contain the 
reducing agent 2-mercaptoethanol. Lanes 6 to 10 were run under 
non-reducing conditions (in the absence of 2-mercaptoethanol). 
No difference can be seen between lanes containing 2-
mercaptoethanol and lanes not containing 2-mercaptoethanol. This 
will be discussed later. 
12345- f 789 
!10000 
Figure 14. Western blot of pP£9 and pP£11 proteins separated by 
SDS-PAGE under both reducing and non-reducing conditions. 
Lane 1, Vici7in/Convici7in Standards. Lane 2, pP£9(MC16) + 2-
mercaptoethanol. Lane 3, pP£11(MC16) + 2-mercaptoethano7. Lane 
4, pDUB2018(MC16) + 2-mercaptoethano7. Lane 5, pMA257(MC16) + 2-
mercaptoethano7. Lane 6, pP£9(MC16). Lane 7, pP£11(MC16). Lane 
8, pDUB2018(MC16). Lane 9, pMA257(MC16). Lanes 6 to 9 were run 
in the absence of 2-mercaptoethano7. 
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4. 3 PPE 1 7: A CONSTRUCT CONTAINING BoTH CYSTEINE MUTATIONS. 
A hybrid vicilin construct pPE17, containing both of the serine 
to cysteine mutations, was made by ligation of the 5' coding 
region from pPE9 to the 3' region from pPE11 through a Pst I site 
in the vicilin eDNA sequence and a Pst I site in the vector (see 
figure 15). 
lsciate 5 · 6 kb 
fragment. 
~€ 
s ';' 
~dW 
~HI 
pPE 11 
~I 1-
_, :I: 
~ ..... ! ...... ~"---' -~' _ _Jf! 
l;!!!!dW 
~HI 
!Isolate 3·9 kb 
~------------.~-u-.-ga-~--------~ f~ment 
~RI 
~HI 
pPE 17 
Figure 15. Construction of pP£17. 
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After transformation into E. co7i 910 a number of transformants 
were analysed by restriction analysis and Southern blotting using 
labelled ol igos 2 and 3 as probes. Figure 16 shows one such 
Southern blot from which sample 1 was selected as being a correct 
cysteine double mutant of vicilin (sample 4 is similar). Sample 
1 shows a positive hybridisation of the 1.4kb Bam HI fragment 
against oligonucleotides 2 and 3, positive hybridisation of the 
5.8kb Pst I fragment against oligonucleotide 2 and positive 
hybridisation of the 4.0kb Pst I fragment against oligonucleotide 
33 • This construct was designated pPE17 and was fully sequenced 
to confirm that the mutations, the rest of the vicilin sequence 
and the PGK promoter sequence were correct. 
The location of the hybridisation sites for oligonucleotides 2 
and 3 within the final vicilin construct, the alteration to the 
amino-acid sequence of the vicilin produced and the extent of the 
sequencing carried out on pPE17 has been summarised in figure 17. 
3See also figure 6 in chapter three. 
1 2 3 4 56 7 8 9101112131415161718 
1 2 
I 
• 
• 
-
.... 
66 
1] Lubda I8U II 
2] pP£9 
3] pOUB2011 
4] SMple 1 BM HI 
5) SMple 2 BMHI 
II) SMple 3 BMHI 
7] SMple 4 BMHI 
I] SMple 1 ht I 
9] SMple 4 ht I 
10) -
11) pPE11 
12] pOUB2011 
13] SMple 1 BM HI 
14) SMple 2 BM HI 
15] Sulple 3 S.. HI 
111] Sulple 4 S.. HI 
17] Sa.ple 1 Pst I 
18] Sulple 4 Pst I 
Figure 16. Agarose ge 7 and subsequent Southern b Jot used to 
identify pP£17. Lanes 1 to 9 of the Southern blot were probed 
with 7abe71ed oligonucleotide 1 and Janes 11 to 18 were probed 
with labelled oligonucleotide 2. Sample 1 was selected and 
designated pP£17. 
10~g of pPE17 plasmid DNA was prepared from a 200 ml culture of 
and used to transform an aliquot of competent S.cerevisiae MC16 
cells as desn.ibed in chapter 2. The transformed S.cerevisiae 
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were again found to express vicilin as determined by an antibody 
screen. 
~ ' ~ ll a a R a c P ll H R R e L K c fl 11 
.'f!.._..zcr TCT JallCT GAT CCT-""------CioC /lltGA/IItGA/IGC CTT A/IGGAT·------L----l 
,GA /lltGA TCC /ICA CTA GG • 3G TCT TCT ACG GAA TTC Co 
.,.___ TCT TCT Jal TGT GM CCT C1oC /lltGA /lltGA TGCCTT A/IG ~-----'------':1 
8 SRCDP HRRCLKD 
• • 
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Figure 17. Position of oligonuceotides 2 and 3 within the 1.4 Kb 
Bam HI insert of pPE17 and sequencing strategy used to confirm 
construct. Not to scale. 
Small scale protein extracts of pPE17 protein were prepared under 
denaturing conditions and were analysed by SDS-PAGE and~estern 
blotting as shown in figure 18. Vicilins were only synthesised 
by constructs containing the eDNA in the 5'-3' orientation 
(construct pPE19 is identical to pPE 17 but with the vicilin eDNA 
cloned in the 3'-5' orientation with respect to the PGK 
promoter). Under non-reducing conditions an additional vicilin 
component of greater mobility was seen with protein produced by 
the pPE17 construct. This was not seen under reducing conditions 
and was not seen with protein produced by the pDUB2018 construct. 
Mr 123456789 
71,000 
eo,ooo 
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Figure 18. Western b7ot analysis of various sma77 sca7e protein 
extracts from yeast. Track 1, vici7in and convici7in Hr 
standards. Tracks 2,3,4 and 5 were run in the presence of 2-
mercaptoethano7. Tracks 6,7,8 and 9 were run under non reducing 
conditions in the absence of 2-mercaptoethano7. Each of tracks 
2-9 contains 501Jg of yeast so7ub7e extract. Tracks 2 and 6, 
pP£19. Tracks 3 and 7, pP£17. Tracks 4 and 8, pP£9. Tracks 5 and 
9, pDUB2018. 
The soluble extracts of 500ml cultures of p0UB2018 and pPE17 were 
subjected to a 45-95~ relative saturation (NH 4 ) 2S04 fraction as 
described in chapter 2. In this case the protein was extracted 
under non-denaturing conditions. The 95~ saturation (NH 4 ) 2S04 
pellets were dissolved in 10 ml of 150 mM sodium phosphate buffer 
pH7.5 and dialysed against 10 mM sodium phosphate buffer pH7.5 
for 24 hours. These extracts were then fractio~ on a 
hydroxyapatite column. Under the conditions employed, vicilin was 
the only component in the extracts to bind to the column and was 
eluted with a phosphate gradient (see figure 19). Protein was 
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estimated by ultraviolet absorption using an extinction 
coefficient E280 1cm of 0.8 for a 1 mg ml-1 solution of vici 1 in. 
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Figure 19. Purification of expressed pPE17 and pDUB2018 vici1in 
by HA-U1troge1 column chromatography. See text for details. 
---, A280 pDUB2018 eluate; ·····, A280 pPE17 eluate; 
----, concentration of sodium phosphate. 
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Both pOUB2018 and pPE17 vicilin were eluted as the phosphate 
concentration was increased to around 250mM (the second peak in 
figure 19 in each case). The first peak in each case repres nts 
unbound material. 
Purified pOUB2018 and pPE17 vicilins were shown to be homogeneous 
in each case by SOS-PAGE, migrating as single species with an Mr 
of approximately 53,000 as shown in figure 20. It was estimated 
by Or Jenny Yarwood that so• of the total sulphur containing 
groups in pPE17 vicilin were present as free sulphydryl groups 
under strongly denaturing conditions by the method of Thannhauser 
et al, 1987. 
Mr 
180,000 
116.000 
84000 
58,000 
1 2 3 4 5 6 7 
Figure 20. SDS-PAGE analysis of fractions from the purification 
of vicilin from yeast. Samples were analysed in the presence of 
2-mercaptoethano1 as indicated in the text. Track 1 contains Hr 
standard proteins (10J.Ig of each). Track 2, pDUB2018 yeast soluble 
extract (100J.Jg). Track 3, 45-95% saturation ammonium sulphate 
fraction of pSUB2018 protein. Track 4, bound peak from HA-
U1troge1 column of pDUB2018 protein. Track 5, pPE17 yeast soluble 
extract (100J.Jg). Track 6, 45-95% saturation ammonium sulphate fraction of pP£17 protein. Track 7, bound peak from HA-U1troge1 
column of pPE17 protein. 
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Analysis of these protein samples by SDS-PAGE and ~estern blot 
analysis under non-reducing conditions revealed the formation of 
specific high molecular weight aggregates by the pPE17 protein 
as shown in figure 21. These aggregates, present in the yeast 
soluble extract, had estimated Mr values of 150,000 and 
approximately 300,000; further species of Mr > 300,000 and 
between 150,000 and 300,000 were present in purified protein. No 
such aggregates were seen with protein samples from pDUB2018. 
1 2 3 4 5 6 7 8 
~.000 
Figure 21. SDS-PAGE and western blot analysis of pDUB2018 and 
pP£17 vici1in under non reducing conditions. Track 1, SDS-PAGE 
of pDUB2018 total soluble extract (100~g). Track 2, SDS-PAGE of 
HA-U1toge1 purified pDUB2018 protein (30~g). Track 3, western 
b1ot of pDUB2018 total soluble extract (100~g). Track 4, western 
b1ot of HA-U1troge1 purified pDUB2018 protein (30~g). Track 5, 
SDS-PAGE of pPE17 tota1 so1ub1e extract (100~g). Track 6, 50S-
PAGE of HA-U1toge1 purified pPE17 protein (30~g). Track 7, 
western b1ot of pP£17 tota1 so1ub1e extract (100~g). Track 8, 
western b1ot of HA-U1toge1 purified pP£17 protein (30~g). 
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Finally, the gelling properties of pPE17 and pOUB2018 vicilins 
were compared by following the gel turbidity of gelling solutions 
of vicilin at increasing temperatures as described in chapter 2. 
It can be seen from figure 22 that the gelling profiles of the 
two proteins are similar. 
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Figure 22. Comparison of Ge77ing Characteristics of pDUB2018 and 
pPE17 Vici7ins. The turbidity of 1mg/m7 solutions of vici7in has 
been recorded for increasing temperatures as described in chapter 
2. 
e pDUB2018 vicilin. A pPE 1 7 vic i 1 i n . 
CHAPTER FIVE 
DISCUSSION 
5. 1 EXPRESSION OF MUTANT VICILINS BY S. CEREVISIAE. 
A vicilin eDNA has been mutated to contain a methionine residue, 
one of two cysteine residues or two cysteine residues. These 
constructs have been expressed in yeast using the PGK expression 
vector pMA257. The encoded proteins migrated as single species 
with Mrs of approximately 53,000 in the presence of 2-
mercaptoethanol as did the non-mutant vicilin produced by 
pDUB2018. The level of vicilin expression in both cases was 
approximately 5% of soluble protein as determined by direct 
protein assay. This is a similar level of expression to other 
heterologous proteins produced from the PGK promoter in yeast 
(Tuite et a7, 1982). 
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5 • 2 THE METHIONINE MUTANT OF VICILIN , 
The purpose of the pPE18 construct was to produce a vicilin clone 
with an easily identified physical change from native vicilin. 
This was to test the application of the mutagenesis system for 
producing a 1 tered homogeneous prate ins. Thus the chances of 
success for studying structure/function relationships using this 
technique could be assessed. CNBr is known to cleave polypeptides 
after methionine residues. As already mentioned, amino acid 
analysis has confirmed that vicilin contains no sulphur-
containing amino acids such as cysteine or methionine (Gatehouse 
et a7, 1984). The incorporation of a single methionine residue 
into vicilin should render the protein cleavable by CNBr and 
provide evidence at the protein level that the mutagenesis has 
been successful. 
The incorporation of a single methionine residue at amino acid 
position 282 of pea vicilin in pPE18 did not alter the level of 
vicilin expression by transgenic S.cerevisiae. Leucine to 
methionine changes are not ,\.,..i:Rfact, uncommon in nature and these 
residues have similar properties. The mutated vicilin eDNA was 
successfully expressed in yeast using the PGK expression vector 
pMA257. The mutant construct (pPE18)J like the original construct 
pDUB2018 and the cysteine mutants pPE9, pPE11 and pPE17J produced 
vicilin that was localised in the cytosol of the yeast and which 
migrated as a single species in SDS-PAGE with an Mr of 
approximately 53,000. This is higher than the 50,000-Mr subunit 
of pea vici 1 in but is most probably due to the additional 22 
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amino acid residues (approximately 3,000 Mr) at the N-terminal 
end encoded by the fusion constructs (Watson et a7, 1988). 
The subcloning and mutagenesis route used to construct the mutant 
along with the restriction analysis and DNA hybridisation carried 
out is illustrated by figures 1 to 6. The expression of vicilin 
by pPE 18 was first detected by the anti body screen shown in 
figure 7. 
The successfu 1 mutation was first indicated by the dot-b 1 ot 
hybridisation and Southern blot shown in figures 3 and 5 
respectively. This was later confirmed by dideoxy sequencing. 
After demonstrating production of vicilin by pPE18 transformed 
S.cerevisiae (figure 7) the effect of CNBr on protein extracts 
was tested. It was found that the vicilin produced by pPE18 was 
cleaved into two subunits ~ approximate Mr 27,000 by CNBr 
(figure 8). Such cleavage did not occur with pDUB2018 vicilin 
which, other than the absence of a methionine residue at position 
282, was identical to pPE18 vicilin. Vicilin was not produced by 
the construct not containing the vicilin insert (pMA257) or by 
constructs containing the vicilin insert cloned in the opposite 
orientation for expression by the PGK promoter. 
Having demonstrated the successfu 1 site-directed mutation of 
vicilin, both at the gene level and by its effect on the protein 
expressed, the introduction of ami no acids thought 1 ike 1 y to 
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effect a change on the physical properties of vicilin was 
considered. 
5. 3 THE CYSTEINE MUTANTS OF VICILIN. 
The incorporation of cysteine residues into vicilin provides the 
basis for cross-linking via S-S bonds. Serine to cysteine changes 
were made as these required only single base changes at the DNA 
level and because serine and cysteine residues are of similar 
size. 
In the intermediate construct pPE9 the single serine residue at 
position 2 of the mature vicilin polypeptide was mutated to 
cysteine whilst in pPE11 the alteration was made to the serine 
at position 183, 3 amino acids N-terminal to the potential a:6 
cleavage site. Both serine 2 and serine 183 are located in 
hydrophilic regions of the vicilin polypeptide, which are likely 
to be on the surface of the vicilin molecule; in addition the 
proximity of serine 183 to the potential proteolysis site 
suggests that this residue is exposed. The hybrid construct pPE17 
contains both mutations and was constructed by ligation of the 
5' coding region from pPE9 to the 3' coding region of pPE11 
through a Pst I site in the vicilin eDNA sequence and a Pst I 
site in the vector. 
The construction of pPE9, pPE10, pPE11 and pPE12 is illustrated 
by figures 9 - 12. Once again vicilin was produced only by 
constructs containing the vicilin insert in the correct 
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orientation for expression from the PGK promoter. The 53,000 Mr 
vicilin produced by pPE9, pPE11 and pOUB2018 can be seen on the 
protein gel shown in figure 13. The western blot (also shown in 
figure 13) shows this more clearly. This figure also illustrates 
that pPE10, pPE12 and pMA257 transformants do not produce 
vicilin. 
As the two cysteine residues were placed in (hopefully) exposed 
regions of the vi ci 1 in peptide it was thought possible that 
cysteine residues might enable sulphydryl bonding between 
neighbouring vicilin molecules and so lead to dimers of vicilin 
being formed. However, no such dimers have been seen by SDS-PAGE 
under non-denaturing, denaturi~g, non-reducing or reducing 
conditions. Figure 14 shows a western blot of pPE9, pPE11 and 
pDUB2018 separated by SDS-PAGE under both reducing and non-
reducing conditions(+/_ 2-mercaptoethanol). It can be seen that 
all the vicilin molecules behave in a similar manner and that the 
introduction of single cysteine residues has had no apparent 
effect on the vicilin produced. 
The hybrid construct, pPE 1 7, was made in order to determine 
whether or not intra-molecular sulphydryl bonds could be formed 
by a mutant vicilin. Figures 15, 16 and 17 show this 
construction. 
SDS-PAGE analysis of pPE17 yeast soluble extracts produced under 
denaturing conditions revealed a vicilin component of greater 
mobility produced only by the pPE17 construct (figure 18). This 
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component was seen on 1 y under non-reducing conditions and is thus 
produced by intramolecular disulphide bonding within the vicilin 
polypeptide. However, this component was only a small proportion 
of the total vicilin (<10%) reflecting the reducing environment 
inside the yeast cell. The vicilins produced by transgenic yeast 
have previously been shown to be located in the yeast cytoplasm. 
pPE17 and pDUB2018 vicilins from non-denatured extracts of 500 
ml YMM cultures were successfully purified by hydroxyapatite 
column chromatography. The binding and elution conditions for 
both proteins were similar and a shouldered elution peak 
characteristic of vicilin was seen in both cases (figure 19). In 
both cases purification was to a single band of Mr 53,000 as seen 
after SDS-PAGE. It was thought that the non-denaturing conditions 
used for protein extraction in this case would maximise the 
chances of seeing sulphydryl bonding in the purified protein. 
When vicilin was extracted from yeast under these non-denaturing 
conditions, formation of disulphide-bonded molecular aggregates 
of vicilin polypeptides was observed on non-reducing SDS-PAGE 
gels (Figure 21 tracks 5 and 7). Aggregation is clearly not a 
random process since in the extract only aggregates corresponding 
to trimers and hexamers of the vicilin polypeptides were 
observed. No band corresponding to the dimer of vicilin 
polypeptides (Mr approximately 100,000) was observed in the yeast 
extract or the purified protein. The purification protocol 
employed to yield pure vicilin was oxidative and formation of 
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additional disulphide bonded aggregates was observed after 
purification (Figure 21 tracks 6 and 8). However, trimers were 
still the major aggregated components present. In both extract 
and purified vicilin approximately 40% of the protein was present 
as disulphide-bonded aggregates. Pea vicilin in vivo exists as 
a trimeric molecule (and as aggregates of these trimers). 
Although the vicilin polypeptides produced in yeast have not been 
shown to have the same conformation as vicilin purified from pea 
seeds, they are nevertheless capable of forming trimeric 
molecules. 
It was hoped that the introduction of cysteine residues into 
vicilin would affect the gelling characteristics of the protein. 
Evidence has been given that the content and reactivity of 
sulphydryl groups in glycinin relate to the strength and 
turbidity of glycinin gels (Nakamura et a7, 1984). However, 
turbidity studies on the purified vicilin subunits produced by 
yeast have not revealed any significant difference between the 
non-mutant vicilin produced by pDUB2018 and the cysteine-
containing vicilin produced by pPE17 (figure 22). Nor were any 
differences detected between the ge 11 i ng characteristics of pPE9, 
pPE11 and pDUB2018 vicilins. 
It may be that the cysteine residues introduced into the vicilin 
subunit are not well placed on the surface of the molecule to be 
reactive, thus they only result in small differences in gel 
turbidity. 
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This project has shown that in vitro mutagenesis can be used 
successfully to alter the amino acid sequence of a cloned protein 
and change its physical properties as a result. A mutant vicilin 
has been produced which contains two cysteine residues and is 
capable of aggregation via disulphide bonding. The door has been 
opened for further physical investigation of this protein and 
comparison with the non-mutant vicilin. Gel-filtration studies 
will more accurately reveal the nature of the oligomers produced. 
Circular dichroism analysis may give insights into the way the 
mutant vicilin molecule is folded and the technique of scanning 
tunnelling microscopy could be used to compare the actual 
physical appearance of mutant and non-mutant vicilin molecules. 
Facilities for this work are not available at Durham Universiy 
but it is hoped that these studies may be carried out at the AFRC 
Research Institute in Norwich. Certainly in vitro mutagenesis is 
a vi ab 1 e technique for studying the re 1 at i onsh i p between a 
protein's physical properties and its primary structure. 
APPENDIX I 
SEQUENCE OF VICILIN CDNA INSERT AND 
CORRESPONDING AMINO ACID SEQUENCE. ALSO SHOWS SITES OF 
HYBRIDISATION OF OLIGONUCLEOTIDES 1 1 2 AND 3 USED FOR THE METHIONINE AND CYSTEINE MUTATIONS 
DESCRIBED IN THE TEXT • 
cOlA 
A.A. 
oligonucleotide 2 
BaJ HI GA AGA TCC ACA CTA GG 
GG ATC CGG TTT TCT TCT AGG TCT GAT CCT CAA AAT CCT TTT ATC TTC AAG TCT AAC AAG TTT CAA ACT CTT TTT GAG 
S S R S 0 P Q H P F I F K S I K F Q T L F E 
N-tenainus 'Y 
c 
Pst I 
68 
cOlA AAT GAA AAT GGG CAC ATT CGA CTT ClG CAG AAA TTT GAC CAA CGT TCT AAA ATT TTC GAG AAT CTA CAA AAC TAC CGT 146 
A.A N E H G H I R l l Q K T 0 Q R S K I F E R l Q N Y R 
cORA CTT TTG GAA TAT AAG TCC AAA CCT CAC ACA ATA TTT CTT CCA CAG CAC ACC GAT GCC GAT TAC ATC CTT GTT GTA CTC 224 
A.A. l l E Y K S K P H T I F l P Q H T 0 A 0 Y I l V V l 
cOlA AGT GGA AAA GCT ATA CTC ACA GTG TTG AAA CCC GAT GAT AGA AAC TCC TTC AAC CTT GAG CGC GGA GAT ACG ATA AAA 302 
A.A. S G K A I L T V L K P 0 0 R H S F N L E R G 0 T I K 
Bg1 II 
eDNA CTT CCT GCT GGC ACA ATT GCT TAT TTG GTT AAC AGA GAT GAC AAC GAG GAG CTT AGA GTA TTA GAT CTC GCC ATT CCC 380 
A.A. l P A G T I A Y L V H R 0 0 N E E L R V L 0 L A I P 
cOMA GTA AAT AGA CCT GGC CAA CTT CAG TCT TTC TTA TTG TCT GGA AAT CAA AAC CAA CAA AAC TAC TTA TCT GGG TTC AGT 458 
A.A. V N R P G Q l Q S F l l S G N Q H Q Q N Y L S G F S 
eDNA AAG AAC ATT CTA GAG GCT TCC TTC AAT ACT GAT TAT GAA GAG ATA GAA AAG GTT CTT TTA GAA GAG CAT GAG AAA GAG 536 
A.A. K H I L E A S F N T 0 Y E E I E K V L L E E H E K E 
cOlA 
A.A. 
em 
A.A. 
cOlA 
A.A. 
oligonucleotide 3 
G TCT TCT ACG GAA TTC C 
AAA GAG ACA CAA CAC AGA AGA AGC CTT AAG GAT AAG AGG CAG CAA AGT CAA GAA GAG AAT GTA ATA GTA AAA TTA TCA 
K E T Q H R R S l K 0 K R Q Q S Q E E R V I V K L S 
'Y 
a:B proteolysis site 
c 
AGG GGA CAA ATT GAG GAA TTG AGT AAA AAT GCA AAG TCT ACC TCC AAA AAA AGT GTT TCC TCT GAA TCT GAA CCA TTC 
R G Q I E E L S K N A K S T S K K S V S S E S E P F 
AAC TTG AGA AGT CGC GGT CCT ATC TAT TCC AAC GAG TTT GGA AAA TTC TTT GAA ATC ACC CCA GAG AAA AAT CCA CAG 
N L R S R G P I Y S H E F G K F F E I T P E K H P Q 
608 
686 
764 
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oligonucleotide 1 
CTT AGA AAT TAC AAC GG 
cORA CTT CAA GAC TTG GAT ATA TTT GTC AAr TCT GTA GAG ATT AAG GAG GGA TCT TTA TTG TTG CCA CAC TAC AAT TCA AGG U2 
A.A. L Q 0 L 0 I F Y N S V E I K E G S L L L P H Y N S R 
.. 
R 
cOlA GCC ATA GTA ATA GTA ACA GTT AAC GAA GGA AAA GGA GAT TTT GAA CTT GTG GGT CAA AGA AAT GAA AAC CAA CAA GAG 920 
A.A. A I V I V T V N E G K G 0 F E L V G Q R N E N Q Q E 
eDNA CAG AGA AAA GAA GAT GAC GAG GAA GAG GAA CAA GGA GAA GAG GAG ATA AAT AAA CAA GTG CAA AAT TAC AAA GCT AAA 998 
A.A. Q R K E 0 D E E E E Q G E E E I N K Q V Q N Y K A K 
B:• proteolysis site 
Hind III 
cORA TTA TCT TCA GGA GAT GTT TTT GTG ATT CCA GCA GGC CAT CCA GTT GCC CTA AAA GCT TCC TCA AAT CTT GAT TTG CTT 1076 
A.A. L S S G D V F V I P A G H P V A L K A S S N L D L L 
cORA GGG TTT GGT ATT AAT GCT GAG AAC AAT CAG AGG AAC TTT CTT GCA GGC GAT GAG GAT AAT GTG ATT AGT CAG ATA CAG 1154 
A.A. G F G I N A E N M Q R N F L A G D E 0 N V I S Q I Q 
cORA CGA CCA GTG AAA GAG CTT GCA TTC CCT GGA TCA GCT CAA GAG GTT GAT AGG ATA CTA GAG AAT CAG AAA CAA TCC CAC 1232 
A.A. R P V K E L A F P G S A Q E V D R I L E N Q K Q S H 
cORA TTT GCA GAT GCT CAA CCT CAA CAA AGG GAG AGA GGA AGT CGT GAA ACA AGA GAT CGT CTA TCT TCA GTT TGA AATGTTT 1311 
A.A. F A 0 A Q P Q Q R E R G S R E T R 0 R L S S V t 
eDNA CTTAATGAGTGGACAAAATACTATGTATGTATGCTATCAAGAGATATATCTCACGGGGAGCAATGAATAAAACAATGTTATCTTATAACiATAATTATATATC 1414 
Bu HI 
eDNA CACTTTTCTACTATGAATA 1433. 
APPENDIX II 
EXAMPLE OF A SUCCESSFUL 
REACTION (SEE SECTION 2-11 
KEY: 
Mutant 
oligorucleotode 
1 
0 -
.. ,3,-,.~0~ 
ssONA 1empla1e 
! 
0 
"'" 0 
~ 
~--0 
~ 
0 
.J 
l'r1onslormoticn 
2 3 4 
e--. + llglllon 
.....,dCTA:!S 
-
+ nic:king 
E......- Ill 
~ion 
Aepolymeriution 
.IN-VITRO MUTAGENESIS 
FOR DETAILS)-
5 6 
-· 
Lane 1 I SAMPLE 1 ; shows 
covalently closed circular 
( ccc) DNA and a saear of 
nicked DNA. 
Lane 2 I SAMPLE 2; shows heavy 
band of nicked DNA and so.e 
ccc DNA. 
Lane 3 I SAMPLE 3; shows DNA 
after exonuclease digestion. 
Lane 41 SAMPLE 4; shoWs DNA 
after repoly .. risation. 
Lane 5 1 Single-stranded M13 
DNA. 
Lane 8 1 Double-stranded M13 
DNA. 
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